ArticleScientific reports2025
The interactions of non-functionalized polystyrene nanoparticles with human albumin and erythrocyte proteins: implications and potential consequences.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A dynamically tunable terahertz human serum albumin biosensor based on Dirac semimetal nanozyme.Frontiers in bioengineering and biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The aim of the study was to determine the concentration- and size-dependent effects of ~30 nm, ~45 nm and ~70 nm non-functionalized polystyrene nanoparticles (PS-NPs) on human serum albumin (HSA) and human erythrocyte proteins in vitro. . HSA or human erythrocytes were exposed to PS-NPs at concentrations ranging from 0.001 to 100 µg/mL for 24 h. Any resulting changes in HSA secondary structure were investigated using circular dichroism (CD), fluorescence spectrum analysis, and fluorescence lifetime measurements. Incubation with 50 µg/mL and 100 µg/mL PS-NPs resulted in an increase in the hydrodynamic diameter of PS-NPs and caused significant alterations in HSA secondary structure for all tested nanoparticle sizes. Additionally, treatment with the ~30 nm and ~45 nm PS-NPs resulted in a more intense HSA fluorescence signal and changes in mean fluorescence lifetimes, indicating interactions between PS-NPs and HSA. Incubation with PS-NPs (0.1-1 µg/mL) also led to significant changes in relative viscosity and increased protein carbonyl content in erythrocytes (10-100 µg/mL); however, no significant changes in acetylcholinesterase (AChE) activity or methemoglobin levels were observed. The study confirms that non-functionalized polystyrene nanoparticles influence the structure and functional properties of human plasma and erythrocyte proteins under in vitro conditions, and their effects are clearly dependent on the size and concentration of the nanoparticles. It is likely that PS-NPs can modify the structure of albumin, which may indirectly potentiate plastic-related damage to erythrocytes in vivo. The potential influence of albumin modified by plastic particles on the properties of human erythrocytes in vivo was discussed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.